China allows foreign investment in manufacturing, health

China will fully open its manufacturing sector to foreign investments and expand opportunities for overseas capital in its health sector as of November 1, 2024.

The National Development and Reform Commission (NDRC) announced the removal of all remaining investment limits in manufacturing, which previously included restrictions on foreign investments in printing factories and Chinese herbal medication production.

Additionally, China will allow foreign capital to engage in advanced healthcare technologies such as stem cells and gene therapies in designated free trade zones.

The new policies also permit the establishment of wholly foreign-owned hospitals in several major cities and regions, though acquisitions of public hospitals and traditional Chinese medicine facilities remain prohibited.

These measures are part of China’s broader efforts to stimulate economic revival and attract international investment.